BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 2460973)

  • 1. Snake venom hemorrhagins: neutralization by commercial antivenoms.
    Mebs D; Pohlmann S; Von Tenspolde W
    Toxicon; 1988; 26(5):453-8. PubMed ID: 2460973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-neutralization of thrombin-like enzymes in snake venoms by polyvalent antivenoms.
    Claus I; Mebs D
    Toxicon; 1989; 27(12):1397-9. PubMed ID: 2629180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross reactivity of mono- and polyvalent antivenoms with Viperidae and Crotalidae snake venoms.
    Kornalík F; Táborská E
    Toxicon; 1989; 27(10):1135-42. PubMed ID: 2815109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical assessment of the ability of polyvalent (Crotalinae) and anticoral (Elapidae) antivenoms produced in Costa Rica to neutralize the venoms of North American snakes.
    Arce V; Rojas E; Ownby CL; Rojas G; Gutiérrez JM
    Toxicon; 2003 Jun; 41(7):851-60. PubMed ID: 12782085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross neutralization of common Southeast Asian viperid venoms by a Thai polyvalent snake antivenom (Hemato Polyvalent Snake Antivenom).
    Leong PK; Tan CH; Sim SM; Fung SY; Sumana K; Sitprija V; Tan NH
    Acta Trop; 2014 Apr; 132():7-14. PubMed ID: 24384454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antivenoms in the neutralization of hyperalgesia and edema induced by Bothrops jararaca and Bothrops asper snake venoms.
    Picolo G; Chacur M; Gutiérrez JM; Teixeira CF; Cury Y
    Braz J Med Biol Res; 2002 Oct; 35(10):1221-8. PubMed ID: 12424496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of four different immunogens for the production of snake antivenoms.
    Li Q; Ownby CL
    Toxicon; 1992 Nov; 30(11):1319-30. PubMed ID: 1485332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross neutralization of coral snake venoms by commercial Australian snake antivenoms.
    Ramos HR; Vassão RC; de Roodt AR; Santos E Silva EC; Mirtschin P; Ho PL; Spencer PJ
    Clin Toxicol (Phila); 2017 Jan; 55(1):33-39. PubMed ID: 27595162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effect of Crotalus simus and Crotalus durissus ruruima venoms on the equine antibody response towards Bothrops asper venom: implications for the production of polyspecific snake antivenoms.
    Dos-Santos MC; Arroyo C; Solano S; Herrera M; Villalta M; Segura A; Estrada R; Gutiérrez JM; León G
    Toxicon; 2011 Feb; 57(2):237-43. PubMed ID: 21130107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of venoms from two Southern Pacific Rattlesnakes (Crotalus helleri) with commercial antivenoms and endothermic animal sera.
    Galán JA; Sánchez EE; Rodríguez-Acosta A; Pérez JC
    Toxicon; 2004 Jun; 43(7):791-9. PubMed ID: 15284013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the intrageneric neutralization scope of monospecific, bispecific/monogeneric and polyspecific/monogeneric antisera raised in horses immunized with sub-Saharan African snake venoms.
    Sánchez A; Durán G; Segura Á; Herrera M; Vargas M; Villalta M; Arguedas M; Moscoso E; Umaña D; Gómez A; Gutiérrez JM; León G
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012187. PubMed ID: 38809847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of phylogeny, venom composition and neutralization by antivenom in diverse species of bothrops complex.
    Sousa LF; Nicolau CA; Peixoto PS; Bernardoni JL; Oliveira SS; Portes-Junior JA; Mourão RH; Lima-dos-Santos I; Sano-Martins IS; Chalkidis HM; Valente RH; Moura-da-Silva AM
    PLoS Negl Trop Dis; 2013; 7(9):e2442. PubMed ID: 24069493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Neutralisation of In Vitro Neurotoxicity of Asian and Australian Snake Neurotoxins and Venoms by Different Antivenoms.
    Silva A; Hodgson WC; Isbister GK
    Toxins (Basel); 2016 Oct; 8(10):. PubMed ID: 27763543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cross neutralization of bothrops jararacussu venom by heterologous antivenoms].
    de Roodt AR; Vidal JC; Litwin S; Dokmetjian JC; Dolab JA; Hajos SE; Segré L
    Medicina (B Aires); 1999; 59(3):238-42. PubMed ID: 10451561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of hemorrhagic snake venoms by sera of Trimeresurus flavoviridis (Habu), Herpestes edwardsii (mongoose) and Dinodon semicarinatus (Akamata).
    Tomihara Y; Kawamura Y; Yonaha K; Nozaki M; Yamakawa M; Yoshida C
    Toxicon; 1990; 28(8):989-91. PubMed ID: 2080520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of hemorrhagic activities of various snake venoms by purified antihemorrhagic factor obtained from Japanese Habu snake.
    Omori-Satoh T; Nagaoka Y; Yamakawa Y; Mebs D
    Toxicon; 1994 Mar; 32(3):365-8. PubMed ID: 8016857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical assessment of the neutralizing efficacy of snake antivenoms in Latin America and the Caribbean: A review.
    Gutiérrez JM
    Toxicon; 2018 May; 146():138-150. PubMed ID: 29510161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.